Concepedia

James D. Warner

JD

4

Publications

1.3K

Citations

4

H-Index

2008

Active since

Affiliations

Pfizer (United States)(Current)

James D. Warner is an author at Pfizer (United States) specializing in medicine, drug development, and oncology.

Top concepts

Publications per year

2008–2017

4

Publications

4

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

Kamran Ghoreschi, Michael I. Jesson, Li Xiong et al. · The Journal of Immunology · 2011 · 628 citations · Full text

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

Debra M. Meyer, Michael I. Jesson, Xiong Li et al. · Journal of Inflammation · 2010 · 455 citations · Full text

STING-associated vasculopathy develops independently of IRF3 in mice

James D. Warner, Ricardo A. Irizarry-Caro, Brock G. Bennion et al. · The Journal of Experimental Medicine · 2017 · 199 citations · Full text

, , +23

Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors

James K. Gierse, Maureen A. Nickols, K. Leahy et al. · European Journal of Pharmacology · 2008 · 34 citations

, , +8

Rows per page

1–4 of 4